Prometheus announces new chief financial officer
This article was originally published in Scrip
The US speciality pharmaceutical company Prometheus Laboratories has named Mark Spring senior vice-president and chief financial officer. Mr Spring has more than 25 years' experience in finance and accounting, having most recently served as senior vice-president and CFO at Hyperion Therapeutics. Before that, he was vice-president of finance and controller of MedImmune.